{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:11:21Z","timestamp":1792300281668,"version":"4.4.0"},"reference-count":97,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T00:00:00Z","timestamp":1337126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Functional dyspepsia (<jats:styled-content style=\"fixed-case\">FD<\/jats:styled-content>), a common functional gastrointestinal disorder, is defined by the <jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>ome <jats:styled-content style=\"fixed-case\">III<\/jats:styled-content> criteria as symptoms of epigastric pain or discomfort (prevalence in <jats:styled-content style=\"fixed-case\">FD<\/jats:styled-content> of 89\u201390%), postprandial fullness (75\u201388%), and early satiety (50\u201382%) within the last 3\u00a0months with symptom onset at least 6\u00a0months earlier. Patients cannot have any evidence of structural disease to explain symptoms and predominant symptoms of gastroesophageal reflux are exclusionary. Symptoms of <jats:styled-content style=\"fixed-case\">FD<\/jats:styled-content> are non\u2010specific and the pathophysiology is diverse, which explains in part why a universally effective treatment for <jats:styled-content style=\"fixed-case\">FD<\/jats:styled-content> remains elusive.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To present current management options for the treatment of <jats:styled-content style=\"fixed-case\">FD<\/jats:styled-content> (therapeutic gain\/response rate noted when available).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The utility of <jats:italic><jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>elicobacter pylori<\/jats:italic> eradication for the treatment of <jats:styled-content style=\"fixed-case\">FD<\/jats:styled-content> is modest (6\u201314% therapeutic gain), while the therapeutic efficacy of proton pump inhibitors (<jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>) (7\u201310% therapeutic gain), histamine\u2010type\u20102\u2010receptor antagonists (8\u201335% therapeutic gain), prokinetic agents (18\u201345%), tricyclic antidepressants (<jats:styled-content style=\"fixed-case\">TCA<\/jats:styled-content>) (response rates of 64\u201370%), serotonin reuptake inhibitors (no better than placebo) is limited and hampered by inadequate data. This review discusses dietary interventions and analyses studies involving complementary and alternative medications, and psychological therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A reasonable treatment approach based on current evidence is to initiate therapy with a daily <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content> in <jats:italic><jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>. pylori<\/jats:italic>\u2010negative <jats:styled-content style=\"fixed-case\">FD<\/jats:styled-content> patients. If symptoms persist, a therapeutic trial with a tricyclic antidepressant may be initiated. If symptoms continue, the clinician can possibly initiate therapy with an anti\u2010nociceptive agent, a prokinetic agent, or some form of <jats:styled-content style=\"fixed-case\">complementary and alternative medications<\/jats:styled-content>, although evidence from prospective studies to support this approach is limited.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2012.05128.x","type":"journal-article","created":{"date-parts":[[2012,5,17]],"date-time":"2012-05-17T15:57:37Z","timestamp":1337270257000},"page":"3-15","source":"Crossref","is-referenced-by-count":192,"title":["Review article: current treatment options and management of functional dyspepsia"],"prefix":"10.1111","volume":"36","author":[{"given":"B. E.","family":"Lacy","sequence":"first","affiliation":[{"name":"Dartmouth\u2010Hitchcock Medical Center Lebanon NH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. J.","family":"Talley","sequence":"additional","affiliation":[{"name":"University of Newcastle Callaghan New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"G. R.","family":"Locke","sequence":"additional","affiliation":[{"name":"Mayo Clinic Rochester MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. P.","family":"Bouras","sequence":"additional","affiliation":[{"name":"Mayo Clinic Jacksonville FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. K.","family":"DiBaise","sequence":"additional","affiliation":[{"name":"Mayo Clinic Scottsdale AZ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. B.","family":"El\u2010Serag","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. P.","family":"Abraham","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. W.","family":"Howden","sequence":"additional","affiliation":[{"name":"Northwestern University Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Moayyedi","sequence":"additional","affiliation":[{"name":"McMaster University Medical Center Hamilton Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Prather","sequence":"additional","affiliation":[{"name":"St. Louis University St. Louis MO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,5,16]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(05)00153-9"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01897.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00454-9"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.099846"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.059"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01381.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.137125"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.05.030"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.09.020"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2007.51-a"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01706.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/gut.50.suppl_4.iv10","article-title":"Clinical and economic consequences of dyspepsia in the community","volume":"50","author":"Moayyedi P","year":"2002","journal-title":"Gut"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.03.003"},{"key":"e_1_2_6_15_1","article-title":"A placebo\u2010controlled trial of acotiamide for meal\u2010related symptoms of functional dyspepsia","author":"Matsueda K","year":"2011","journal-title":"Gut"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01262.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.09.007"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.00288.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02212683"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.3.347"},{"key":"e_1_2_6_21_1","first-page":"520","article-title":"Eating patterns in functional dyspepsia: a case control study","volume":"50","author":"Cuperus P","year":"1996","journal-title":"Eur J Clin Nutr"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0698-8"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33663"},{"key":"e_1_2_6_24_1","first-page":"CD002096","article-title":"Eradication of Helicobacter pylori for non\u2010ulcer dyspepsia","volume":"2","author":"Moayyedi P","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_25_1","first-page":"3242","article-title":"Symptom\u2010based tendencies of Helicobacter Pylori eradication in patients with functional dyspepsia","volume":"17","author":"Lan L","year":"2011","journal-title":"World J Gastroenterol"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.533"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2004.04.003"},{"key":"e_1_2_6_28_1","first-page":"CD001960","article-title":"Pharmacological interventions for non\u2010ulcer dyspepsia","volume":"4","author":"Moayyedi P","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.4.473"},{"key":"e_1_2_6_30_1","first-page":"980","article-title":"Symptomatic treatment of nonulcer dyspepsia with cimetidine","volume":"37","author":"Delattre M","year":"1985","journal-title":"Curr Therapeutic Res"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528809093840"},{"key":"e_1_2_6_32_1","first-page":"590","article-title":"Clinical investigation of ranitidine in patients with gastritis","volume":"11","author":"Hadi S","year":"1989","journal-title":"Clin Ther"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00368.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02470.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.0954-6820.1985.tb02696.x","article-title":"Controlled clinical trial of treatment with cimetidine for non\u2010ulcer dyspepsia","volume":"213","author":"Kelbaek H","year":"1985","journal-title":"Acta Med Scand"},{"key":"e_1_2_6_36_1","first-page":"1130","article-title":"Ranitidine in the Treatment of Non\u2010Ulcer Dyspepsia. A placebo\u2010controlled study in the Federal Republic of Germany [Ranitidin in der Behandlung derNon\u2013Ulcer\u2013Dyspepsie. Eine placebo\u2013kontrollierte Studie in der Bundesrepublic Deutschland]","volume":"10","author":"Muller P","year":"1994","journal-title":"Arzneimittelforschung\/Drug Res"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528509089708"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528609093787"},{"key":"e_1_2_6_39_1","first-page":"665","article-title":"Dyspepsia: incidence of a non\u2010ulcer disease in a controlled trial of ranitidine in general practice","volume":"1986","author":"Saunders JH","year":"1994","journal-title":"Br Med J (Clin Res Ed)"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007998909110140"},{"key":"e_1_2_6_41_1","first-page":"411","article-title":"Cisapride compared with ranitidine in the treatment of functional dyspepsia","volume":"7","author":"Carvalhinhos A","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_42_1","first-page":"397","article-title":"Cimetidine vs antacids in non\u2010ulcer dyspepsia","volume":"39","author":"Casiraghi A","year":"1986","journal-title":"Curr Ther Res Clin Exp"},{"key":"e_1_2_6_43_1","first-page":"7","article-title":"Sucralfate versus ranitidine in non\u2010ulcer dyspepsia: results of a prospective, randomized, open, controlled trial","volume":"11","author":"Misra SP","year":"1992","journal-title":"Indian J Gastroenterol"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00410.x"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.4.473"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/003655202762671260"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.4.502"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.01.008"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00751.x"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802184545"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03410.x"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.09.012"},{"key":"e_1_2_6_53_1","first-page":"1906","article-title":"Tegaserod treatment for dysmotility\u2010like functional dyspepsia: results of two randomized, controlled trials","volume":"103","author":"Vakil N","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052639"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.132449"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01236.x"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00868.x"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2010.482927"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2009.45.12.1423115"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005454.pub2"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.163162"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1586\/egh.09.73"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1159\/000088363"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2007.01029.x"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.02021.x"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00160.x"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02473.x"},{"issue":"1","key":"e_1_2_6_68_1","first-page":"S\u201050","article-title":"A randomized, double\u2010blind, placebo\u2010controlled trial of low dose imipramine for treatment of refractory functional dyspepsia (FD)","volume":"140","author":"Wu JC","year":"2011","journal-title":"Gastroenterology"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07699.x"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.27180"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.051"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1038"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2012.02.002"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01261.x"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01449.x"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2011.00028"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3283249c7b"},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.18.1569"},{"key":"e_1_2_6_79_1","volume-title":"Complementary and Alternative Medicine use Among Adults: United States, 2002","author":"Barnes PM","year":"2004"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.1159\/000076546"},{"key":"e_1_2_6_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.01183.x"},{"key":"e_1_2_6_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2008.01249.x"},{"key":"e_1_2_6_83_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01767.x"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00873.x"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90402-Q"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2008.04.004"},{"key":"e_1_2_6_87_1","doi-asserted-by":"publisher","DOI":"10.1080\/16506078809456271"},{"key":"e_1_2_6_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(94)90026-4"},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.16493"},{"key":"e_1_2_6_90_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.37071"},{"key":"e_1_2_6_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03005.x"},{"key":"e_1_2_6_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(02)00170-7"},{"key":"e_1_2_6_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(98)00175-4"},{"key":"e_1_2_6_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01922.x"},{"key":"e_1_2_6_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03676.x"},{"key":"e_1_2_6_96_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2638"},{"key":"e_1_2_6_97_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.069088"},{"key":"e_1_2_6_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03986.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2012.05128.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2012.05128.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T12:57:07Z","timestamp":1700571427000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2012.05128.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,16]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1111\/j.1365-2036.2012.05128.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2012.05128.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,16]]}}}